Food and Drug Administration officials have finalized guidelines that make it easier for pharmaceutical companies to use medical journal articles to promote drugs for unapproved uses.
The final guidelines, which have been criticized by some lawmakers as too lenient, allow companies to distribute articles about their products to doctorseven when they involve uses that have not been federally approved.
The FDA document, posted online Monday, comes just days before the Bush administration turns over power to President-elect Obamas government. On the campaign trail, Obama criticized pharmaceutical industry efforts to court physicians.
Story continues below